Immunotherapy with γδ T-cells: the future is there

被引：1
|
作者：
Kabelitz, Dieter [1 ,2 ]
Yin, Zhinan [3 ,4 ,5 ]
机构：
[1] Univ Kiel, Inst Immunol, Campus Kiel, D-24105 Kiel, Germany
[2] Univ Hosp Schleswig Holstein, Campus Kiel, D-24105 Kiel, Germany
[3] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Inst Translat Med, Guangdong Prov Key Lab Tumor Intervent Diag & Trea, Zhuhai 519000, Peoples R China
[4] Jinan Univ, Sch Med, State Key Lab Bioact Mol & Druggabil Assessment, Guangzhou 510632, Peoples R China
[5] Jinan Univ, Minist Educ, Key Lab Viral Pathogenesis Infect Prevent & Contro, Guangzhou 510632, Peoples R China
来源：
IMMUNOTHERAPY | 2024年 / 16卷 / 11期
关键词：
adoptive cell therapy; bispecific T-cell engager; chimeric antigen receptor; delta one T-cells; immunotherapy; phosphoantigen; vitamin C; gamma delta T-cells;
D O I：
10.1080/1750743X.2024.2365622
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：705 / 708
页数：4
相关论文
共 50 条
  • [41] Immunotherapy of malignant pleural nnesothelioma using MET specific T-cells
    Thayaparan, T.
    Stegen, S. J.
    Puri, A. C. Parente Pereira
    Petrovic, R. M.
    Spicer, J.
    Maher, J.
    LUNG CANCER, 2015, 87 : S21 - S21
  • [42] Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
    Hawkins, Elizabeth R.
    D'Souza, Reena R.
    Klampatsa, Astero
    BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 95 - 105
  • [43] Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers
    Gotti, Manuel
    Defrancesco, Irene
    D'Angelo, Mario
    Basso, Sabrina
    Crotto, Luca
    Marinelli, Alfredo
    Maccalli, Cristina
    Iaconianni, Vincenzo
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [44] T-cells cultured with adenovirus peptides recognise adenovirus infected cells: an option for immunotherapy?
    van Tol, M
    Heemskerk, B
    Sombroek, C
    van Vreeswijk, T
    Havenga, M
    Schilham, M
    Veltrop-Duits, L
    BONE MARROW TRANSPLANTATION, 2005, 35 : S2 - S2
  • [45] Engineering strategies to safely drive CAR T-cells into the future
    Rossi, Matteo
    Breman, Eytan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [46] Fertility and CAR T-cells: Current practice and future directions
    Ligon, John A.
    Fry, Abigail
    Maher, Jacqueline Y.
    Foley, Toni
    Silbert, Sara
    Yates, Bonnie
    Gomez-Lobo, Veronica
    Wiener, Lori
    Shah, Nirali N.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (09): : 605.e1 - 605.e8
  • [47] T-CELLS
    TALWAR, GP
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 1977, 14 (01): : 8 - 8
  • [48] Alloreactive and leukaemia-reactive T-cells mainly derive from naive precursors in healthy donors: implications for immunotherapy with memory T-cells
    Distler, E.
    Bloetz, A.
    Albrecht, J.
    Asdufan, S.
    Hohberger, A.
    Frey, M.
    Schnuerer, E.
    Thomas, S.
    Theobald, M.
    Hartwig, U. F.
    Herr, W.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S317 - S317
  • [49] γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy
    Papadakos, Stavros P.
    Arvanitakis, Konstantinos
    Stergiou, Ioanna E.
    Koutsompina, Maria-Loukia
    Germanidis, Georgios
    Theocharis, Stamatios
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [50] γδ T cells in cancer immunotherapy: current status and future prospects
    Chiplunkar, Shubhada
    Dhar, Swati
    Wesch, Daniela
    Kabelitz, Dieter
    IMMUNOTHERAPY, 2009, 1 (04) : 663 - 678
12345